|
|
|
|
|
|
Neurocrine Bioscienc (NBIX)
|
|
52.15 -0.97 (-1.83%)
|
8/18/2017 4:00pm
|
|
Open:
|
53.00
|
Pre. Close:
|
53.12
|
|
High:
|
53.78
|
Low:
|
52.07
|
|
Volume:
|
778,086
|
Market Cap:
|
4.60B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
54.52 - 55.64
|
55.64 - 56.44
|
|
Low:
|
49.67 - 50.76
|
50.76 - 51.53
|
|
Close:
|
50.48 - 52.3
|
52.3 - 53.59
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-18 4:44:45 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 64.50 One year: 75.33
|
|
Support:
|
Support1: 49.60 Support2: 46.13
|
|
Resistance:
|
Resistance1:
55.22 Resistance2: 64.50
|
|
Pivot:
|
52.26 
|
|
Moving Averages:
|
MA(5): 53.37  MA(20): 51.43
MA(100): 48.70 MA(250): 46.75
|
|
MACD:
|
MACD(12,26):
1.55 Signal(12,26,9): 1.59
|
|
%K %D:
|
%K(14,3): 72.26 %D(3): 78.53
|
|
RSI:
|
RSI(14): 56.24
|
|
52-Week:
|
High: 55.38
Low: 37.35 Change(%): 1.2
|
|
Average Vol(K):
|
3-Month: 96014
10-Days 43454
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.NBIX has closed above bottom band by 48.9%. Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 16 Aug 2017 15:33:45 GMT
Neurocrine Biosciences: Ingrezza's Strong Launch, Pipeline To Create Value
Fri, 04 Aug 2017 14:48:45 GMT
Neurocrine Biosciences Off To A Good Start With Ingrezza
Fri, 28 Jul 2017 16:52:30 GMT
Neurocrine Biosciences Announces Conference Call and Webcast to Report Second ...
Thu, 16 Feb 2017 16:49:11 GMT
Neurocrine Biosciences Building Toward Bigger Things
Fri, 03 Feb 2017 20:15:00 GMT
The Positive Investment Case For Neurocrine Biosciences
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
